Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
FOX FOX	$50.52 -0.4%	$50.30	$27.63 ▼ $55.00	$22.91B	0.74	1.18 million shs	849,055 shs
GM General Motors	$46.65 -1.2%	$48.89	$38.96 ▼ $61.24	$46.45B	1.42	13.33 million shs	18.82 million shs
HOG Harley-Davidson	$25.08 -3.3%	$26.29	$23.81 ▼ $43.89	$3.12B	1.49	1.86 million shs	1.84 million shs
LLY Eli Lilly and Company	$820.30 -0.2%	$844.31	$711.40 ▼ $972.53	$777.78B	0.34	3.31 million shs	2.12 million shs
MRK Merck & Co., Inc.	$89.18 +1.8%	$91.92	$81.04 ▼ $134.63	$221.28B	0.35	11.05 million shs	12.39 million shs
PFE Pfizer	$25.20 +0.8%	$26.06	$24.48 ▼ $31.54	$142.93B	0.61	39.04 million shs	32.32 million shs
TGNA TEGNA	$18.10 -1.1%	$18.03	$12.35 ▼ $19.62	$2.92B	0.45	1.98 million shs	1.45 million shs
THO THOR Industries	$77.02 -4.7%	$94.11	$75.78 ▼ $118.85	$4.10B	1.74	589,163 shs	781,027 shs
VTRS Viatris	$8.68 -1.8%	$10.27	$8.62 ▼ $13.55	$10.36B	0.92	9.33 million shs	11.27 million shs

12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
FOX FOX	0.00%	+1.65%	-4.50%	+8.34%	+76.64%
GM General Motors	0.00%	-6.27%	-2.15%	-14.05%	+4.59%
HOG Harley-Davidson	0.00%	+1.78%	-4.83%	-17.16%	-42.56%
LLY Eli Lilly and Company	0.00%	-2.28%	-9.34%	+4.74%	+5.34%
MRK Merck & Co., Inc.	0.00%	-4.56%	-1.55%	-10.55%	-32.31%
PFE Pfizer	0.00%	-3.83%	-3.39%	-5.33%	-9.25%
TGNA TEGNA	0.00%	-2.32%	+0.58%	-1.55%	+21.85%
THO THOR Industries	0.00%	-2.64%	-21.64%	-19.24%	-32.81%
VTRS Viatris	0.00%	-5.14%	-8.92%	-30.45%	-26.63%

Remove Ads

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
FOX FOX	2.7527 of 5 stars	0.0	3.0	2.5	2.9	1.0	2.5	1.9
GM General Motors	4.9207 of 5 stars	4.2	3.0	2.5	0.0	2.4	3.3	3.8
HOG Harley-Davidson	4.9611 of 5 stars	4.2	3.0	2.5	0.0	3.4	2.5	4.4
LLY Eli Lilly and Company	4.801 of 5 stars	2.4	5.0	3.3	4.0	3.4	2.5	1.9
MRK Merck & Co., Inc.	5 of 5 stars	4.3	5.0	5.0	3.9	2.7	3.3	3.8
PFE Pfizer	4.9866 of 5 stars	3.3	3.0	4.2	4.2	3.3	3.3	3.1
TGNA TEGNA	2.5018 of 5 stars	2.4	2.0	2.5	0.0	2.9	1.7	1.3
THO THOR Industries	4.4954 of 5 stars	3.1	1.0	4.2	1.4	3.2	1.7	2.5
VTRS Viatris	1.8679 of 5 stars	1.9	3.0	2.5	0.0	2.3	1.7	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
FOX FOX	2.00	Hold	N/A	N/A
GM General Motors	2.41	Hold	$62.11	33.14% Upside
HOG Harley-Davidson	2.38	Hold	$33.57	33.84% Upside
LLY Eli Lilly and Company	2.85	Moderate Buy	$1,009.72	23.09% Upside
MRK Merck & Co., Inc.	2.65	Moderate Buy	$117.12	31.33% Upside
PFE Pfizer	2.63	Moderate Buy	$31.92	26.67% Upside
TGNA TEGNA	2.75	Moderate Buy	$21.75	20.20% Upside
THO THOR Industries	2.25	Hold	$93.00	20.74% Upside
VTRS Viatris	1.75	Reduce	$10.50	20.97% Upside

Current Analyst Ratings Breakdown

Latest THO, VTRS, TGNA, GM, HOG, PFE, MRK, LLY, and FOX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
3/27/2025	GM General Motors	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$64.00 ➝ $53.00
3/20/2025	GM General Motors	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$45.00 ➝ $48.00
3/20/2025	THO THOR Industries	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sector Weight ➝ Underweight	$65.00
3/19/2025	THO THOR Industries	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell	$65.00
3/19/2025	THO THOR Industries	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$94.00 ➝ $86.00
3/18/2025	PFE Pfizer	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
3/12/2025	PFE Pfizer	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
3/10/2025	PFE Pfizer	Hsbc Global Res Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
3/7/2025	GM General Motors	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$105.00
3/7/2025	THO THOR Industries	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$95.00 ➝ $80.00
3/7/2025	VTRS Viatris	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$15.00 ➝ $13.00

(Data available from 3/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
FOX FOX	$15.18B	1.51	$4.21 per share	12.01	$25.61 per share	1.97
GM General Motors	$187.44B	0.25	$22.65 per share	2.06	$65.92 per share	0.71
HOG Harley-Davidson	$5.19B	0.60	$7.79 per share	3.22	$24.81 per share	1.01
LLY Eli Lilly and Company	$45.04B	17.27	$13.37 per share	61.34	$15.05 per share	54.50
MRK Merck & Co., Inc.	$64.17B	3.51	$3.09 per share	28.82	$14.85 per share	6.01
PFE Pfizer	$63.63B	2.25	$3.95 per share	6.38	$15.81 per share	1.59
TGNA TEGNA	$3.10B	0.93	$2.45 per share	7.39	$13.73 per share	1.32
THO THOR Industries	$9.50B	0.43	$8.29 per share	9.29	$76.58 per share	1.01
VTRS Viatris	$14.74B	0.70	$4.11 per share	2.11	$17.06 per share	0.51

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
FOX FOX	$1.50B	$4.67	10.82	11.53	1.55	14.39%	18.50%	9.22%	5/6/2025 (Estimated)
GM General Motors	$6.01B	$6.15	7.59	3.95	0.67	3.21%	15.29%	3.82%	4/29/2025 (Estimated)
HOG Harley-Davidson	$455.36M	$3.33	7.53	5.66	0.38	9.25%	13.64%	3.64%	4/24/2025 (Estimated)
LLY Eli Lilly and Company	$10.59B	$11.71	70.05	26.36	1.40	23.51%	85.24%	16.19%	5/1/2025 (Estimated)
MRK Merck & Co., Inc.	$17.12B	$6.73	13.25	9.01	0.77	26.67%	45.35%	17.36%	4/24/2025 (Estimated)
PFE Pfizer	$8.03B	$1.41	17.87	8.32	0.64	12.62%	19.47%	8.09%	4/29/2025 (Estimated)
TGNA TEGNA	$476.72M	$3.54	6.39	10.77	N/A	16.75%	14.49%	5.70%	5/8/2025 (Estimated)
THO THOR Industries	$265.31M	$3.77	19.70	12.38	1.16	2.17%	5.97%	3.39%	6/4/2025 (Estimated)
VTRS Viatris	$54.70M	-$0.53	N/A	3.38	N/A	-5.87%	16.46%	7.09%	5/8/2025 (Estimated)

Latest THO, VTRS, TGNA, GM, HOG, PFE, MRK, LLY, and FOX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
4/24/2025	N/A	HOG Harley-Davidson	$0.90	N/A	N/A	N/A	$1.12 billion	N/A
4/24/2025	N/A	MRK Merck & Co., Inc.	$2.16	N/A	N/A	N/A	$15.59 billion	N/A
4/22/2025	N/A	GM General Motors	$2.63	N/A	N/A	N/A	N/A	N/A
3/5/2025	Q2 2025	THO THOR Industries	$0.07	-$0.01	-$0.08	-$0.01	$1.98 billion	$2.02 billion
2/27/2025	Q4 24	VTRS Viatris	$0.57	$0.54	-$0.03	-$0.43	$3.60 billion	$3.53 billion
2/6/2025	Q4 2024	LLY Eli Lilly and Company	$5.45	$5.32	-$0.13	$4.88	$13.42 billion	N/A
2/5/2025	Q4 2024	HOG Harley-Davidson	-$0.65	-$0.93	-$0.28	-$0.93	$470.33 million	N/A
2/4/2025	Q2 25	FOX FOX	$0.61	$0.96	+$0.35	$0.81	N/A	N/A
2/4/2025	Q4 2024	MRK Merck & Co., Inc.	$1.85	$1.72	-$0.13	$1.48	$15.51 billion	$15.62 billion
2/4/2025	Q4 2024	PFE Pfizer	$0.48	$0.63	+$0.15	$0.07	$17.26 billion	$17.76 billion
1/28/2025	Q4 2024	GM General Motors	$1.75	$1.92	+$0.17	-$1.64	$42.29 billion	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
FOX FOX	$0.54	1.07%	+4.09%	11.56%	N/A
GM General Motors	$0.48	1.03%	N/A	7.80%	N/A
HOG Harley-Davidson	$0.72	2.87%	+4.77%	21.62%	N/A
LLY Eli Lilly and Company	$6.00	0.73%	+15.21%	51.24%	11 Years
MRK Merck & Co., Inc.	$3.24	3.63%	+5.73%	48.14%	14 Years
PFE Pfizer	$1.72	6.83%	+2.50%	121.99%	16 Years
TGNA TEGNA	$0.50	2.76%	+11.25%	14.12%	N/A
THO THOR Industries	$2.00	2.60%	+5.27%	53.05%	15 Years
VTRS Viatris	$0.48	5.53%	+13.30%	N/A	N/A

Latest THO, VTRS, TGNA, GM, HOG, PFE, MRK, LLY, and FOX Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
3/25/2025	THO THOR Industries	quarterly	$0.50	2.49%	4/8/2025	4/8/2025	4/22/2025
1/28/2025	MRK Merck & Co., Inc.	quarterly	$0.81	3.32%	3/17/2025	3/17/2025	4/7/2025
2/11/2025	TGNA TEGNA	quarterly	$0.1250	2.72%	3/7/2025	3/7/2025	4/1/2025
2/3/2025	FOX FOX	quarterly	$0.27	2.2%	3/5/2025	3/5/2025	3/26/2025
1/27/2025	GM General Motors	quarterly	$0.12	0.87%	3/7/2025	3/7/2025	3/20/2025
2/24/2025	VTRS Viatris	quarterly	$0.12	5.2%	3/10/2025	3/10/2025	3/18/2025
2/14/2025	HOG Harley-Davidson	quarterly	$0.18	2.8%	2/28/2025	2/28/2025	3/14/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
FOX FOX	0.57	2.50	2.14
GM General Motors	1.38	1.13	0.98
HOG Harley-Davidson	1.41	1.40	1.19
LLY Eli Lilly and Company	2.00	1.15	0.97
MRK Merck & Co., Inc.	0.79	1.36	1.15
PFE Pfizer	0.63	1.00	0.73
TGNA TEGNA	1.07	2.60	2.60
THO THOR Industries	0.26	1.71	0.78
VTRS Viatris	0.82	1.51	0.96

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
FOX FOX	26.41%
GM General Motors	92.67%
HOG Harley-Davidson	85.10%
LLY Eli Lilly and Company	82.53%
MRK Merck & Co., Inc.	76.07%
PFE Pfizer	68.36%
TGNA TEGNA	92.19%
THO THOR Industries	96.71%
VTRS Viatris	79.88%

Insider Ownership

Company	Insider Ownership
FOX FOX	23.06%
GM General Motors	0.72%
HOG Harley-Davidson	0.87%
LLY Eli Lilly and Company	0.13%
MRK Merck & Co., Inc.	0.09%
PFE Pfizer	0.06%
TGNA TEGNA	0.88%
THO THOR Industries	4.50%
VTRS Viatris	0.13%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
FOX FOX	10,600	453.43 million	348.87 million	Optionable
GM General Motors	167,000	995.00 million	987.84 million	Optionable
HOG Harley-Davidson	6,300	124.54 million	126.22 million	Optionable
LLY Eli Lilly and Company	39,000	948.17 million	948.08 million	Optionable
MRK Merck & Co., Inc.	69,000	2.53 billion	2.53 billion	Optionable
PFE Pfizer	83,000	5.67 billion	5.66 billion	Optionable
TGNA TEGNA	6,200	159.90 million	159.70 million	Optionable
THO THOR Industries	32,000	53.20 million	50.83 million	Optionable
VTRS Viatris	37,000	1.19 billion	1.19 billion	Optionable

THO, VTRS, TGNA, GM, HOG, PFE, MRK, LLY, and FOX Headlines

Recent News About These Companies

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Viatris Inc. Investors to Inquire About Securities Class Action Investigation - VTRS

March 30 at 6:02 PM | markets.businessinsider.com

Viatris Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - VTRS

March 30 at 3:23 PM | accessnewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viatris Inc. - VTRS

March 30 at 9:00 AM | investing.com

Shareholder Rights Advocates at Levi & Korsinsky Investigate Viatris Inc. (VTRS) Regarding Possible Securities Fraud Violations

March 30 at 6:53 AM | accessnewswire.com

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris

March 30 at 6:44 AM | globenewswire.com

Lost Money on Viatris Inc.(VTRS)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky

March 29 at 6:01 PM | accessnewswire.com

VTRS Investor News: Rosen Law Firm Encourages Viatris Inc. ...

March 29 at 1:46 PM | gurufocus.com

VTRS Investor News: Rosen Law Firm Encourages Viatris Inc. Investors to Inquire About Securities Class Action Investigation - VTRS

March 29 at 11:54 AM | prnewswire.com

VIATRIS Investors Are Encouraged to Contact Kaplan Fox & Kilsheimer LLP Regarding Potential Securities Law Violations

March 29 at 11:28 AM | theglobeandmail.com

ROSEN, A LEADING LAW FIRM, Encourages Viatris Inc. Investors to Inquire About Securities Class Action Investigation - VTRS

March 28 at 8:27 PM | markets.businessinsider.com

An Investigation Has Commenced on Behalf of Viatris Inc. Shareholders. Contact Levi & Korsinsky to Discuss your VTRS Losses

March 28 at 3:25 PM | accessnewswire.com

VTRS ACTIVE INVESTIGATION: Contact Levi & Korsinsky if You Lost Money on Your Viatris Inc. Investment

March 28 at 10:30 AM | accessnewswire.com

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris

March 28 at 9:50 AM | prnewswire.com

Viatris to Report First Quarter 2025 Financial Results on May 8, 2025

March 28 at 7:04 AM | prnewswire.com

VTRS STOCK ALERT: Levi & Korsinsky Notifies Viatris Inc. Investors of an Ongoing Investigation

March 27 at 6:30 PM | accessnewswire.com

An Investigation Has Commenced on Behalf of Viatris Inc. Shareholders. Contact Levi & Korsinsky to Discuss your VTRS Losses.

March 27 at 5:30 PM | accessnewswire.com

Viatris Inc. (VTRS) Faces Investor Scrutiny After Possible Disclosure Delay About June 2024 FDA Inspection of Manufacturing Facility – Hagens Berman

March 27 at 5:05 PM | globenewswire.com

Viatris Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - VTRS

March 27 at 1:45 PM | accessnewswire.com

Viatris Inc. Announcement: If You Have Suffered Losses in Viatris Inc. (NASDAQ: VTRS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

March 27 at 1:17 PM | globenewswire.com

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Inquire About Securities Class Action Investigation - VTRS

March 27 at 10:52 AM | markets.businessinsider.com

2 Generic Drug Stocks Ready to Surge in 2025

November 27, 2024 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

BYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?
By Jeffrey Neal Johnson | March 21, 2025
View BYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?
Word-of-Mouth Winners: 2 Stocks Growing Without Big Ad Budgets
By Leo Miller | March 21, 2025
View Word-of-Mouth Winners: 2 Stocks Growing Without Big Ad Budgets
Intel Foundry’s Moment of Truth: Will 18A Deliver?
By Jeffrey Neal Johnson | March 6, 2025
View Intel Foundry’s Moment of Truth: Will 18A Deliver?
3 ETFs to Ride the VIX Surge During Market Volatility
By Nathan Reiff | March 23, 2025
View 3 ETFs to Ride the VIX Surge During Market Volatility
Missed the Hims & Hers Rally? Clover Health Could Be Next
By Gabriel Osorio-Mazilli | March 5, 2025
View Missed the Hims & Hers Rally? Clover Health Could Be Next

THO, VTRS, TGNA, GM, HOG, PFE, MRK, LLY, and FOX Company Descriptions

FOX NASDAQ:FOX

$50.52 -0.21 (-0.41%)

As of 03/28/2025 04:00 PM Eastern

Fox Corporation operates as a news, sports, and entertainment company in the United States (U.S.). The company operates through four segments: Cable Network Programming, Television, Credible, and The FOX Studio Lot. The Cable Network Programming segment produces and licenses news and sports content for distribution through traditional cable television systems, direct broadcast satellite operators and telecommunication companies, virtual multi-channel video programming distributors, and other digital platforms primarily in the U.S. Television segment produces, acquires, markets, and distributes programming through the FOX broadcast network, advertising supported video-on-demand service Tubi, and operates power broadcast television stations including duopolies and other digital platform; and produces content for third parties. The Credible segment engages in the consumer finance marketplace. The FOX Studio Lot segment provides television and film production services along with office space, studio operation services and includes all operations of the facility. The company was incorporated in 2018 and is headquartered in New York, New York.

General Motors NYSE:GM

$46.65 -0.55 (-1.16%)

Closing price 03/28/2025 03:59 PM Eastern

Extended Trading

$46.72 +0.06 (+0.14%)

As of 03/28/2025 07:55 PM Eastern

General Motors Company designs, builds, and sells trucks, crossovers, cars, and automobile parts; and provide software-enabled services and subscriptions worldwide. The company operates through GM North America, GM International, Cruise, and GM Financial segments. It markets its vehicles primarily under the Buick, Cadillac, Chevrolet, GMC, Baojun, and Wuling brand names. In addition, the company sells trucks, crossovers, cars, and automobile parts through retail dealers, and distributors and dealers, as well as to fleet customers, including daily rental car companies, commercial fleet customers, leasing companies, and governments. Further, it offers range of after-sale services through dealer network, such as maintenance, light repairs, collision repairs, vehicle accessories, and extended service warranties. Additionally, the company provides automotive financing; and software-enabled services and subscriptions. General Motors Company was founded in 1908 and is headquartered in Detroit, Michigan.

Harley-Davidson NYSE:HOG

$25.08 -0.86 (-3.30%)

Closing price 03/28/2025 03:59 PM Eastern

Extended Trading

$25.14 +0.05 (+0.20%)

As of 03/28/2025 07:31 PM Eastern

Harley-Davidson, Inc. manufactures and sells motorcycles in the United States and internationally. The company operates in three segments: Harley-Davidson Motor Company, LiveWire, and Harley-Davidson Financial Services. The Harley-Davidson Motor Company segment designs, manufactures, and sells motorcycles, including cruiser, trike, touring, standard, sportbike, adventure, and dual sport, as well as motorcycle parts, accessories, and apparel, as well as licenses its trademarks and related services. This segment sells its products to retail customers through a network of independent dealers, as well as e-commerce channels. The LiveWire segment sells electric motorcycles, balance bikes for kids, parts and accessories, apparel, and related parts and services. The Harley-Davidson Financial Services segment provides wholesale financing services, such as floorplan and open account financing of motorcycles, and parts and accessories; and retail financing services, such as installment lending for the purchase of new and used Harley-Davidson motorcycles, as well as point-of-sale insurance and voluntary protection products. This segment also licenses third-party financial institutions that issue credit cards bearing the Harley-Davidson brand. Harley-Davidson, Inc. was founded in 1903 and is based in Milwaukee, Wisconsin.

Eli Lilly and Company NYSE:LLY

$820.30 -1.37 (-0.17%)

Closing price 03/28/2025 03:59 PM Eastern

Extended Trading

$815.45 -4.85 (-0.59%)

As of 03/28/2025 07:57 PM Eastern

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Merck & Co., Inc. NYSE:MRK

$89.18 +1.58 (+1.80%)

Closing price 03/28/2025 03:59 PM Eastern

Extended Trading

$89.15 -0.03 (-0.03%)

As of 03/28/2025 07:55 PM Eastern

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Pfizer NYSE:PFE

$25.20 +0.19 (+0.76%)

Closing price 03/28/2025 03:59 PM Eastern

Extended Trading

$25.14 -0.07 (-0.26%)

As of 03/28/2025 07:59 PM Eastern

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

TEGNA NYSE:TGNA

$18.10 -0.20 (-1.07%)

Closing price 03/28/2025 03:59 PM Eastern

Extended Trading

$18.08 -0.01 (-0.06%)

As of 03/28/2025 06:35 PM Eastern

TEGNA Inc., a media company, provides broadcast advertising and marketing products and services for businesses. The company operates 47 television stations in 39 markets of the United States that produce local programming, such as news, sports, and entertainment. It offers local and national non-political advertising; political advertising; production of programming from third parties; production of advertising materials; and digital marketing services, as well as advertising services on the stations' Websites, tablets, and mobile products. The company also sells commercial advertising spots of its television stations. In addition, it operates Premion, an over the top local advertising network; Hatch, a centralized 360-degree marketing services agency; and radio broadcast stations. The company was formerly known as Gannett Co., Inc. and changed its name to TEGNA Inc. in June 2015. TEGNA Inc. was founded in 1906 and is headquartered in McLean, Virginia.

THOR Industries NYSE:THO

$77.02 -3.81 (-4.71%)

Closing price 03/28/2025 03:59 PM Eastern

Extended Trading

$77.23 +0.21 (+0.27%)

As of 03/28/2025 07:49 PM Eastern

THOR Industries, Inc. designs, manufactures, and sells recreational vehicles (RVs), and related parts and accessories in the United States, Canada, and Europe. The company offers travel trailers; gasoline and diesel Class A, Class B, and Class C motorhomes; conventional travel trailers and fifth wheels; luxury fifth wheels; and motorcaravans, caravans, campervans, and urban vehicles. It also provides aluminum extrusion and specialized component products to RV and other manufacturers. The company provides its products through independent and non-franchise dealers. THOR Industries, Inc. was incorporated in 1980 and is based in Elkhart, Indiana.

Viatris NASDAQ:VTRS

$8.68 -0.16 (-1.81%)

Closing price 03/28/2025 04:00 PM Eastern

Extended Trading

$8.70 +0.02 (+0.18%)

As of 03/28/2025 07:55 PM Eastern

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides it medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as glargine and SEMGLEE names. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; and Momenta Pharmaceuticals, Inc. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare MarketRank™

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest THO, VTRS, TGNA, GM, HOG, PFE, MRK, LLY, and FOX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest THO, VTRS, TGNA, GM, HOG, PFE, MRK, LLY, and FOX Earnings

Compare Dividends

Latest THO, VTRS, TGNA, GM, HOG, PFE, MRK, LLY, and FOX Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

THO, VTRS, TGNA, GM, HOG, PFE, MRK, LLY, and FOX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

THO, VTRS, TGNA, GM, HOG, PFE, MRK, LLY, and FOX Company Descriptions

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools